EICHORCondition: Rheumatoid Arthritis · Sponsor: Gilead Sciences
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goals of this clinical study are to learn more about the study drug, GS-0272, and its safety and tolerability following multiple doses in participants with rheumatoid arthritis (RA). The primary objectives of this study are to assess the safety and tolerability of multiple ascending doses of GS-0272 and to characterize the pharmacokinetics of GS-0272 following multiple doses of GS-0272, in participants with RA.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona Arthritis & Rheumatology Associates P.C. | Glendale, California, United States | — |
| Stanford School of Medicine, Division of Immunology & Rheumatology | Palo Alto, California, United States | — |
| 1238 E. Arrow Hwy | Upland, California, United States | — |
| Clinical Research of West Florida, Inc. | Clearwater, Florida, United States | — |
| Jacksonville Center for Clinical Research | Jacksonville, Florida, United States | — |
| Greater Chicago Specialty Physicians/ Clinical Investigation Specialists | Niles, Illinois, United States | — |
| Greater Chicago Specialty Physicians/Clinical Investigation Specialists, Inc. | Schaumburg, Illinois, United States | — |
| Summit Headlands LLC | Portland, Oregon, United States | — |
| Altoona Center for Clinical Research | Duncansville, Pennsylvania, United States | — |
| PA Regional Center for Arthritis and Osteoporosis Research | Wyomissing, Pennsylvania, United States | — |
| Precision Comprehensive Clinical Research Solutions | Colleyville, Texas, United States | — |
| Accurate Clinical Research, Inc. | Houston, Texas, United States | — |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06031415